Delivery Order SPE2DB20D3303-SPE2DB25FA2GD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.46 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $37,479.45 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. The contract was completed on August 22, 2025, with performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication, with a ceiling value of $8,524.93. This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,608.41 by the Defense Logistics Agency on April 29, 2025, with an ultimate completion date of April 30, 2025. The award covers Trelegy Ellipta 200-62.5-25, a combination respiratory medication used for chronic obstructive pulmonary disease and asthma management. This is a firm fixed-price delivery order with no set-aside designation, issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $23,940.27 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, with an ultimate completion date of August 28, 2025. The delivery order, issued without set-aside designation through competitive procedures, covers TRELEGY ELLIPTA 200-62.5-25 (a combination inhalation medication for chronic obstructive pulmonary disease) in a 60-unit...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for $9,101.14 to supply Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by September 2, 2025, at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a ceiling value of $33,303.92. This firm fixed-price delivery order, which is not set-aside designated, was awarded competitively and is scheduled for completion by August 27, 2025. The award was fulfilled by AmerisourceBergen's Corporate Office division based in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication) in a 60-dose unit. Valued at approximately $14,000, this firm fixed-price delivery order represents a non-competitive set-aside award issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2GDDelivery Order
AmerisourceBergen Drug Corp received a delivery order valued at $1,513.12 from the Defense Logistics Agency (DLA) on August 7, 2025, for Trelegy Ellipta 200-62.5-25, a combination respiratory medication used in treating chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. This delivery order is performed at the company's corporate office location in Conshohocken, Pennsylvania, and is a child contract under AmerisourceBergen's larger relationship with the federal procurement system. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving military and federal healthcare systems, AmerisourceBergen fulfills critical pharmaceutical supply needs across multiple therapeutic domains through this comprehensive contract vehicle. The DLA Troop Support Medical IDC enables the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/7/25 |